Page last updated: 2024-10-30

metformin and Disease

metformin has been researched along with Disease in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Disease: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.

Research Excerpts

ExcerptRelevanceReference
"Metformin is a safe, effective and useful drug for glucose management in patients with diabetes."2.66The Use of Metformin to Increase the Human Healthspan. ( Lushchak, O; Piskovatska, V; Storey, KB; Vaiserman, AM, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Piskovatska, V1
Storey, KB1
Vaiserman, AM1
Lushchak, O1
Kanigur Sultuybek, G1
Soydas, T1
Yenmis, G1

Reviews

2 reviews available for metformin and Disease

ArticleYear
The Use of Metformin to Increase the Human Healthspan.
    Advances in experimental medicine and biology, 2020, Volume: 1260

    Topics: Aged; Aging; Clinical Trials as Topic; Disease; Frailty; Humans; Longevity; Metformin

2020
NF-κB as the mediator of metformin's effect on ageing and ageing-related diseases.
    Clinical and experimental pharmacology & physiology, 2019, Volume: 46, Issue:5

    Topics: Aging; Animals; Disease; Humans; Metformin; Molecular Targeted Therapy; NF-kappa B

2019